HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

No randomized trial shows ezetimibe alone lowers heart attacks; don't swap it for a statin

Louis Nervegna · Oct 31, 2026 · ♥ 15 reactions · 7 comments · original Facebook post
PCSK9, ezetimibe & newer drugsStatins
↻ This is a repost. The main version (highest ranked) is No randomized trial shows ezetimibe alone lowers heart attack or stroke risk · Aug 13, 2026.
AI summary & key facts

Louis warns against stopping a statin and switching to ezetimibe monotherapy, because no randomized trial has shown ezetimibe by itself reduces heart attacks or strokes. This is why cardiologists usually add ezetimibe to statins rather than replace them.

(no text — see the shared post below)

Thinking of stopping your statin and switching to ezetimibe?

You’re taking a big risk…

No randomized trial has ever shown that ezetimibe by itself lowers risk of heart attacks and strokes.

This is why most cardiologists hesitate to prescribe ezetimibe as a monotherapy. They usually prescribe it in addition to statins, not in place of them.

Reference for video clip:
facebook.com/share/v/19AGc6yVcz

#ezetimibeHD #statinsHD #statinsezetimibeHD #ezetimibemonotherapyHD

← newer: Six statin trials show 5 to 17% total plaque reversal, with older: PCSK9 inhibitors are proven to cut heart attacks only when c →